The Global Blood Collection Market was valued at USD 10.8 billion in 2025 and is estimated to grow at a CAGR of 6.2% to reach USD 19.5 billion by 2035.
Growth is supported by the rising global disease burden, continuous progress in blood collection technologies, and the increasing volume of medical procedures performed worldwide. As healthcare systems place greater emphasis on early detection, routine monitoring, and precision-based treatment, the demand for accurate and efficient blood sampling continues to rise. Blood collection remains a foundational step in diagnostic workflows, supporting disease detection, therapy evaluation, and long-term patient monitoring across multiple care settings. The growing number of clinical interventions further reinforces demand, as blood-based assessments are required throughout patient evaluation and recovery processes. Advancements in collection methods, safety-focused designs, and workflow efficiency are also contributing to broader adoption. Together, these factors are strengthening market growth while reinforcing the importance of reliable blood collection solutions across hospitals, laboratories, and point-of-care environments.
The consumables category generated USD 8.2 billion in 2025. This segment includes single-use products essential for collecting, handling, and transporting blood samples. Due to their disposable nature, these items are required for every blood draw, making them indispensable across healthcare facilities. Consumables play a critical role in maintaining sample integrity, preventing contamination, and ensuring accurate diagnostic outcomes. Their widespread and repetitive use continues to drive consistent demand across clinical and laboratory settings.
The diagnostics segment held 50.7% share in 2025. This segment encompasses devices and consumables used to collect and analyze blood samples for disease identification, monitoring, and management. Rising demand for routine testing and long-term condition management has increased reliance on efficient and advanced blood collection systems, supporting sustained growth in this segment.
North America Blood Collection Market accounted for 35.4% share in 2025. Regional growth is driven by high diagnostic testing volumes, well-established healthcare infrastructure, and a rapidly aging population. Increasing healthcare utilization among older individuals has led to higher demand for blood-based diagnostic tools, reinforcing market expansion across the region.
Key companies operating in the Global Blood Collection Market include Thermo Fisher Scientific, Becton, Dickinson, and Company, Abbott Laboratories, Siemens Healthineers, Cardinal Health, McKesson Corporation, Terumo Corporation, Greiner, Sarstedt AG & Co, Nipro Corporation, QIAGEN, Streck, Haemonetics Corporation, F. Hoffmann-La Roche, Fresenius SE & Co, and FL MEDICAL. Companies in the blood collection market are strengthening their market position through product innovation, safety enhancements, and expanded distribution networks. Manufacturers are investing in user-friendly, safety-engineered designs to reduce contamination risks and improve clinical efficiency. Emphasis on automation and compatibility with advanced diagnostic platforms helps streamline laboratory workflows. Strategic partnerships with healthcare providers and distributors support broader market reach. Firms are also expanding manufacturing capacity to meet rising global demand while ensuring regulatory compliance. Continuous focus on quality assurance, cost optimization, and sustainability initiatives further enhances competitiveness, allowing companies to maintain strong relationships with healthcare systems and reinforce long-term market presence.
This product will be delivered within 2-4 business days.
Growth is supported by the rising global disease burden, continuous progress in blood collection technologies, and the increasing volume of medical procedures performed worldwide. As healthcare systems place greater emphasis on early detection, routine monitoring, and precision-based treatment, the demand for accurate and efficient blood sampling continues to rise. Blood collection remains a foundational step in diagnostic workflows, supporting disease detection, therapy evaluation, and long-term patient monitoring across multiple care settings. The growing number of clinical interventions further reinforces demand, as blood-based assessments are required throughout patient evaluation and recovery processes. Advancements in collection methods, safety-focused designs, and workflow efficiency are also contributing to broader adoption. Together, these factors are strengthening market growth while reinforcing the importance of reliable blood collection solutions across hospitals, laboratories, and point-of-care environments.
The consumables category generated USD 8.2 billion in 2025. This segment includes single-use products essential for collecting, handling, and transporting blood samples. Due to their disposable nature, these items are required for every blood draw, making them indispensable across healthcare facilities. Consumables play a critical role in maintaining sample integrity, preventing contamination, and ensuring accurate diagnostic outcomes. Their widespread and repetitive use continues to drive consistent demand across clinical and laboratory settings.
The diagnostics segment held 50.7% share in 2025. This segment encompasses devices and consumables used to collect and analyze blood samples for disease identification, monitoring, and management. Rising demand for routine testing and long-term condition management has increased reliance on efficient and advanced blood collection systems, supporting sustained growth in this segment.
North America Blood Collection Market accounted for 35.4% share in 2025. Regional growth is driven by high diagnostic testing volumes, well-established healthcare infrastructure, and a rapidly aging population. Increasing healthcare utilization among older individuals has led to higher demand for blood-based diagnostic tools, reinforcing market expansion across the region.
Key companies operating in the Global Blood Collection Market include Thermo Fisher Scientific, Becton, Dickinson, and Company, Abbott Laboratories, Siemens Healthineers, Cardinal Health, McKesson Corporation, Terumo Corporation, Greiner, Sarstedt AG & Co, Nipro Corporation, QIAGEN, Streck, Haemonetics Corporation, F. Hoffmann-La Roche, Fresenius SE & Co, and FL MEDICAL. Companies in the blood collection market are strengthening their market position through product innovation, safety enhancements, and expanded distribution networks. Manufacturers are investing in user-friendly, safety-engineered designs to reduce contamination risks and improve clinical efficiency. Emphasis on automation and compatibility with advanced diagnostic platforms helps streamline laboratory workflows. Strategic partnerships with healthcare providers and distributors support broader market reach. Firms are also expanding manufacturing capacity to meet rising global demand while ensuring regulatory compliance. Continuous focus on quality assurance, cost optimization, and sustainability initiatives further enhances competitiveness, allowing companies to maintain strong relationships with healthcare systems and reinforce long-term market presence.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Product Type, 2021-2034 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Method, 2021-2034 ($ Mn)
Chapter 7 Market Estimates and Forecast, by Application, 2021-2034 ($ Mn)
Chapter 8 Market Estimates and Forecast, by End Use, 2021-2034 ($ Mn)
Chapter 9 Market Estimates and Forecast, by Region, 2021-2034 ($ Mn)
Chapter 10 Company Profiles
Companies Mentioned
The companies profiled in this Blood Collection market report include:- Abbott Laboratories
- Becton, Dickinson, and Company
- Cardinal Health
- F. Hoffmann-La Roche
- FL MEDICAL
- Fresenius SE & Co
- Greiner
- Haemonetics Corporation
- McKesson Corporation
- Nipro Corporation
- QIAGEN
- Sarstedt AG & Co
- Siemens Healthineers
- Streck
- Terumo Corporation
- Thermo Fisher Scientific
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | February 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 10.8 Billion |
| Forecasted Market Value ( USD | $ 19.5 Billion |
| Compound Annual Growth Rate | 6.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
